STVN Price Prediction Next Week
Technical Analysis: Based on recent price action, STVN has shown significant weakness, falling from $33.28 to $19.54, representing a 41.3% decline. The stock is currently trading below all major moving averages (5-day: $20.00, 10-day: $21.11, 20-day: $21.42).
Key technical indicators show bearish signals:
- RSI-14 at 36.97 indicates oversold conditions
- MACD is negative at -0.52 with bearish crossover
- Stochastic RSI (14,14,3,3) at extremely low levels of 8.33
Support/Resistance Levels:
- Immediate support: $19.06 (Fibonacci S1)
- Strong support: $17.99 (Fibonacci S2)
- Resistance: $22.52 (Fibonacci R1)
News Impact: Recent news indicates significant selling pressure, with the stock falling 16.1% in pre-market trading on February 14th. This sharp decline followed a 5% drop in the previous session, suggesting deteriorating market sentiment.
Price Prediction for Next Week: Based on technical analysis and recent price action, STVN is likely to trade between $17.99-$19.06 next week. The probability distribution for different scenarios:
- Bearish scenario (70%): Further decline to $17.99
- Neutral scenario (20%): Consolidation around $19.00
- Bullish scenario (10%): Bounce to $20.00
Recommendation: SELL
- Entry point: Current price ($19.54)
- Target: $17.99
- Stop loss: $20.50
Rationale:
- Bearish technical indicators
- Below all major moving averages
- Negative news sentiment
- Weak market momentum
The stock shows strong bearish momentum and lacks clear catalysts for immediate recovery. Traders should consider taking short positions or liquidating existing long positions.
STVN Similar Chart Price Prediction
The price of STVN is predicted to go up 5.95%, based on the high correlation periods with HOPE. The similarity of these two price pattern on the periods is 94.91%.
STVN
HOPE
Up: 5.95%Similarity: 94.91%
STVN Revenue Forecast
STVN EPS Forecast
STVN FAQs
What is bull’s view on STVN?
What is bear's view on STVN?
What is STVN revenue forecast for next quarter？
What is STVN eps forecast for next quarter？
STVN Analyst's Forecast
Derik De Bruin
B of A Securities
Strong Buy
2024-12-13
Price Target
$24 → $26
Upside
+11.54%
BofA raised the firm's price target on Stevanato Group to $26 from $24 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech customers reined in spending after overspending during the pandemic and China remained "very subdued," the analyst tells investors. Entering 2025, "the setup is almost identical, so there is a healthy dose of skepticism among investors who have been burned over the past year," says the firm, which adds that thinks "there are finally some encouraging signs on the horizon." In conjunction with its year ahead preview for the group, the firm adjusted a number of price targets.
Doug Schenkel
Wolfe Research
Buy
2024-12-13
Price Target
$28
Upside
+20.12%
Tejas Savant
Morgan Stanley
Hold
2024-12-03
Price Target
$24 → $23
Upside
+14.6%
